Rx groups call on FDA to ease entry of biosimilars
The National Association of Chain Drug Stores, National Community Pharmacists Association and American Pharmacists Association (APhA), have made recommendations to the Food and Drug Administration aimed at facilitating the entry of lower-cost products into the biologic and specialty pharmaceutical m